British Journal of Pharmacology · 2006 · 74 citations · 32 references
MedicineNeurosciencePharmacologyMolecular NeuroscienceNeuropharmacologyPsychopharmacologyAntidepressant PharmacotherapyAntidepressant TherapyNeural Stem Cell BiologyNeural Stem CellsNeurogenesisNeuroprotectionAntidepressant EfficacyAntidepressant MedicationsBcl-2 Protein ExpressionExtracellular Signal-regulated Kinase PathwayExtracellular Signal-regulated Kinase SignalingNeural Cell DifferentiationNeural Stem Cell DifferentiationPharmacology Of Serotonergic Agents
1. Moclobemide (MB) is an antidepressant drug that selectively and reversibly inhibits monoamine oxidase-A. Recent studies have revealed that antidepressant drugs possess the characters of potent growth-promoting factors for the development of neurogenesis and improve the survival rate of serotonin (5-hydroxytrytamine; 5-HT) neurons. However, whether MB comprises neuroprotection effects or modulates the proliferation of neural stem cells (NSCs) needs to be elucidated. 2. In this study, firstly, we used the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay to demonstrate that 50 microM MB can increase the cell viability of NSCs. The result of real-time reverse transcription-polymerase chain reaction (RT-PCR) showed that the induction of MB can upregulate the gene expressions of Bcl-2 and Bcl-xL. By using caspases 8 and 3, ELISA and terminal dUTP nick-end labeling (TUNEL) assay, our data further confirmed that 50 microM MB-treated NSCs can prevent FasL-induced apoptosis. 3. The morphological findings also supported the evidence that MB can facilitate the dendritic development and increase the neurite expansion of NSCs. Moreover, we found that MB treatment increased the expression of Bcl-2 in NSCs through activating the extracellular-regulated kinase (ERK) phosphorylation. 4. By using the triple-staining immunofluorescent study, the percentages of serotonin- and MAP-2-positive cells in the day 7 culture of MB-treated NSCs were significantly increased (P<0.01). Furthermore, our data supported that MB treatment increased functional production of serotonin in NSCs via the modulation of ERK1/2. In sum, the study results support that MB can upregulate Bcl-2 expression and induce the differentiation of NSCs into serotoninergic neuron via ERK pathway.
32
Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants
Luca Santarelli, Michael Saxe, Cornelius T. Gross et al. · Science · 2003 · 4.3K citations · Full text
Medicine, Neurobiology, Neuroscience +16
Identification of a Neural Stem Cell in the Adult Mammalian Central Nervous System
Clas B. Johansson, Stefan Momma, Diana L. Clarke et al. · Cell · 1999 · 1.9K citations · Full text